96 related articles for article (PubMed ID: 31944535)
1. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.
Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B
Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
Mao L; Qi Z; Zhang L; Guo J; Si L
Front Immunol; 2021; 12():680407. PubMed ID: 34149718
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy and Immunotherapy for Melanoma in Japan.
Namikawa K; Yamazaki N
Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668
[TBL] [Abstract][Full Text] [Related]
4. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet radiation drives mutations in a subset of mucosal melanomas.
Mundra PA; Dhomen N; Rodrigues M; Mikkelsen LH; Cassoux N; Brooks K; Valpione S; Reis-Filho JS; Heegaard S; Stern MH; Roman-Roman S; Marais R
Nat Commun; 2021 Jan; 12(1):259. PubMed ID: 33431815
[TBL] [Abstract][Full Text] [Related]
6. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma.
Furney SJ; Turajlic S; Stamp G; Nohadani M; Carlisle A; Thomas JM; Hayes A; Strauss D; Gore M; van den Oord J; Larkin J; Marais R
J Pathol; 2013 Jul; 230(3):261-9. PubMed ID: 23620124
[TBL] [Abstract][Full Text] [Related]
7. Rates of
Gottesdiener LS; O'Connor S; Busam KJ; Won H; Solit DB; Hyman DM; Shoushtari AN
Clin Cancer Res; 2018 Dec; 24(23):5815-5819. PubMed ID: 30093446
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary approach and treatment of acral and mucosal melanoma.
Fortuna A; Amaral T
Front Oncol; 2024; 14():1340408. PubMed ID: 38469235
[TBL] [Abstract][Full Text] [Related]
9. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.
Yang C; Sanchez-Vega F; Chang JC; Chatila WK; Shoushtari AN; Ladanyi M; Travis WD; Busam KJ; Rekhtman N
Mod Pathol; 2020 Nov; 33(11):2244-2255. PubMed ID: 32581366
[TBL] [Abstract][Full Text] [Related]
10. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway.
Elder DE; Bastian BC; Cree IA; Massi D; Scolyer RA
Arch Pathol Lab Med; 2020 Apr; 144(4):500-522. PubMed ID: 32057276
[TBL] [Abstract][Full Text] [Related]
11. The mutational landscape of mucosal melanoma.
Nassar KW; Tan AC
Semin Cancer Biol; 2020 Apr; 61():139-148. PubMed ID: 31655118
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
Zhang J; Tian H; Mao L; Si L
Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
[TBL] [Abstract][Full Text] [Related]
13. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.
Rabbie R; Ferguson P; Molina-Aguilar C; Adams DJ; Robles-Espinoza CD
J Pathol; 2019 Apr; 247(5):539-551. PubMed ID: 30511391
[TBL] [Abstract][Full Text] [Related]
14. Acral cutaneous melanoma in a Spanish Caucasian population.
Avilés-Izquierdo JA; Longo-Imedio MI; Lázaro-Ochaita P
Melanoma Res; 2010 Jun; ():. PubMed ID: 20585270
[TBL] [Abstract][Full Text] [Related]
15. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
Ichimura N; Urata Y; Kobayashi T; Hibi H
Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing of matched primary and metastatic acral melanomas.
Turajlic S; Furney SJ; Lambros MB; Mitsopoulos C; Kozarewa I; Geyer FC; Mackay A; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Thomas M; Stamp G; Larkin J; Reis-Filho JS; Marais R
Genome Res; 2012 Feb; 22(2):196-207. PubMed ID: 22183965
[TBL] [Abstract][Full Text] [Related]
17. NUAK2: an emerging acral melanoma oncogene.
Namiki T; Coelho SG; Hearing VJ
Oncotarget; 2011 Sep; 2(9):695-704. PubMed ID: 21911917
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterisation of acral melanoma cell lines.
Furney SJ; Turajlic S; Fenwick K; Lambros MB; MacKay A; Ricken G; Mitsopoulos C; Kozarewa I; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Reis-Filho JS; Herlyn M; Murata H; Marais R
Pigment Cell Melanoma Res; 2012 Jul; 25(4):488-92. PubMed ID: 22578220
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CCNE1 copy number gain in acral melanoma patients.
Wu X; Yan J; Yu J; Cheng Z; Guo Q; Kong Y; Guo J
Melanoma Res; 2021 Aug; 31(4):352-357. PubMed ID: 33965974
[TBL] [Abstract][Full Text] [Related]
20. Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma.
Chang JW; Huang CJ; Huang WK; Wang YC; Hsieh JJ; Chang YY; Huang YL; Wu CL; Wang YH; Chen SJ; Tan KT; Chen CP; Wu CE
Clin Transl Immunology; 2023; 12(8):e1465. PubMed ID: 37649975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
